2022 annual financial data

Xenon Pharmaceuticals 2022 Net margin

Direct answer

Net margin was -1,328.95%.

Operating income was -129,143,000 USD and net income was -125,373,000 USD.
Operating cash flow was -98,430,000 USD.

Get free Xenon Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
9,434,000 USD
Operating income
-129,143,000 USD
Net income
-125,373,000 USD
Operating cash flow
-98,430,000 USD